Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study

Feasibility of using P16 methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study

Abstract Background Early diagnosis and treatment of esophageal squamous cell dysplasia (ESCdys) and esophageal squamous cell carcinoma (ESCC) could significantly reduce the incidence and mortality of ESCC. This pilot study aimed to investigate whether P16/CDKN2A methylation could serve as a cytolog...

Full description

Bibliographic Details
Main Authors: Zhiyuan Fan, Yu Qin, Jing Zhou, Ru Chen, Jianhua Gu, Minjuan Li, Jiachen Zhou, Xinqing Li, Dongmei Lin, Jinwu Wang, Dajun Deng, Wenqiang Wei
Format: Article
Language:English
Published: Wiley 2022-11-01
Series:Cancer Medicine
Subjects:
cytology
early detection
esophageal squamous cell carcinoma
minimally invasiveness
P16 methylation
Online Access:https://doi.org/10.1002/cam4.4718

Internet

https://doi.org/10.1002/cam4.4718

Similar Items